Outcome of pulmonary hypertension associated with respiratory disease

L. Piccari (Barcelona, Spain), I. Blanco (Barcelona, Spain), M. López-Meseguer (Barcelona, Spain), R. Del Pozo (Huelva, Spain), X. Pomares (Sabadell, Spain), S. Santos (Barcelona, Spain), J. De Miguel (Madrid, Spain), G. Juan (Valencia, Spain), M. Rodríguez (Madrid, Spain), E. Sala (Palma de Mallorca, Spain), L. Jara (Sevilla, Spain), J. Domingo-Morera (Zaragoza, Spain), P. Escribano-Subías (Madrid, Spain), A. Martínez-Menaca (Santander, Spain), G. Pérez (Canarias, Spain), J. Barberà (Barcelona, Spain), D. Rodríguez (Barcelona, Spain)

Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Session: Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Session type: Thematic Poster
Number: 1431
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Piccari (Barcelona, Spain), I. Blanco (Barcelona, Spain), M. López-Meseguer (Barcelona, Spain), R. Del Pozo (Huelva, Spain), X. Pomares (Sabadell, Spain), S. Santos (Barcelona, Spain), J. De Miguel (Madrid, Spain), G. Juan (Valencia, Spain), M. Rodríguez (Madrid, Spain), E. Sala (Palma de Mallorca, Spain), L. Jara (Sevilla, Spain), J. Domingo-Morera (Zaragoza, Spain), P. Escribano-Subías (Madrid, Spain), A. Martínez-Menaca (Santander, Spain), G. Pérez (Canarias, Spain), J. Barberà (Barcelona, Spain), D. Rodríguez (Barcelona, Spain). Outcome of pulmonary hypertension associated with respiratory disease. 1431

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Pulmonary hypertension in left heart, respiratory and trombo-embolic pulmonary disease
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Pulmonary hypertension in patients with COPD
Source: Eur Respir Mon 2012; 57: 138-147
Year: 2012


Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases
Source: Eur Respir Monogr 2020; 88: 167-183
Year: 2020


Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012


Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010

EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Disease-targeted treatment improves cognitive function in patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015


Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history
Source: Eur Respir Rev 2009; 18: 170-173
Year: 2009



Predictors of non-invasive ventilation outcome in chronic obstructive pulmonary disease and pneumonia
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011

Anxiety and affecting factors in pulmonary rehabilitation patients with chronic obstructive pulmonary disease during exacerbation
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011

Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002

Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010